NVAX
Novavax Inc
NASDAQ: NVAX · HEALTHCARE · BIOTECHNOLOGY
$7.93
-0.56% today
Updated 2026-04-30
Market cap
$1.31B
P/E ratio
3.09
P/S ratio
1.17x
EPS (TTM)
$2.58
Dividend yield
—
52W range
$6 – $12
Volume
4.2M
Novavax Inc (NVAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $84.38M | $121.88M | $91.29M | $76.63M | $85.61M | $74.84M | $66.58M | $102.34M | $235.94M | $276.00M | $386.04M | $394.30M | $302.49M | $207.98M | $172.96M | $1.58B | $2.58B | $2.26B | $1.80B | $1.56B |
| Cash & equivalents | $31.89M | $7.16M | $4.35M | $26.94M | $38.76M | $8.06M | $14.10M | $17.40M | $119.47M | $32.34M | $93.11M | $144.35M | $106.31M | $70.15M | $78.82M | $553.40M | $1.52B | $1.34B | $568.50M | $530.23M |
| Current assets | $37.61M | $77.34M | $49.02M | $35.10M | $44.50M | $33.34M | $26.11M | $50.41M | $145.00M | $188.16M | $287.26M | $287.83M | $203.31M | $119.28M | $97.25M | $1.25B | $2.16B | $1.70B | $1.14B | $1.13B |
| Total liabilities | $34.73M | $27.88M | $28.23M | $31.14M | $11.14M | $15.79M | $12.73M | $22.11M | $32.70M | $46.38M | $93.37M | $399.85M | $404.23M | $375.91M | $358.97M | $955.27M | $2.93B | $2.89B | $2.51B | $2.18B |
| Current liabilities | $4.88M | $5.34M | $6.21M | $27.72M | $8.03M | $10.27M | $7.58M | $11.68M | $18.93M | $34.12M | $76.49M | $66.41M | $73.67M | $45.54M | $25.80M | $322.04M | $2.39B | $2.46B | $1.64B | $1.15B |
| Long-term debt | $29.68M | $22.46M | $21.63M | $480000.00 | $406000.00 | $320000.00 | $300000.00 | $753000.00 | $1.00M | $503000.00 | $37000.00 | $316.34M | $317.76M | $319.19M | $320.61M | $322.04M | $323.46M | $166.47M | $168.02M | $169.68M |
| Shareholder equity | $49.65M | $94.00M | $63.06M | $45.49M | $74.47M | $59.05M | $53.85M | $80.24M | $203.23M | $229.62M | $292.67M | $-5.55M | $-101.73M | $-167.94M | $-186.02M | $627.21M | $-351.67M | $-634.08M | $-716.93M | $-623.84M |
| Retained earnings | $-141.89M | $-164.96M | $-199.73M | $-235.78M | $-274.15M | $-310.29M | $-329.66M | $-358.16M | $-410.15M | $-493.09M | $-650.03M | $-930.00M | $-1.11B | $-1.30B | $-1.43B | $-1.87B | $-3.62B | $-4.28B | $-4.82B | $-5.01B |
| Accounts receivable | $3.57M | $2.12M | $667000.00 | $290000.00 | $258000.00 | $54000.00 | $3.80M | $2.58M | $6.90M | $10.61M | $2.32M | $233000.00 | $37.91M | $-70.32M | $7.50M | $262.01M | $454.99M | $82.38M | $297.24M | $108.28M |
| Inventory | $800000.00 | $600000.00 | $25000.00 | $42000.00 | — | — | $2.44M | $3.54M | $4.46M | $7.56M | $12.97M | $15.74M | $13.09M | $11.97M | $-82.97M | $-166.67M | $-1.96B | $36.68M | $41.70M | $8.75M |
| Goodwill | $33.14M | $33.14M | $33.14M | $33.14M | $33.14M | $33.14M | $33.14M | $33.14M | $59.52M | $54.61M | $53.06M | $51.67M | $53.56M | $51.97M | $51.15M | $135.38M | $131.48M | $126.33M | $127.45M | $107.48M |